Resultado de búsqueda
Hace 4 días · Eisai anunció la finalización de su colaboración estratégica mundial con Bristol Myers Squibb para desarrollar y comercializar conjuntamente el conjugado anticuerpo-fármaco (ADC), farletuzumab ecteribulina (FZEC). Anteriormente conocido como MORAb-202, FZEC es un ADC dirigido al receptor de folato alfa (FRα).
Hace 11 horas · PRINCETON, N.J., July 08, 2024--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in Virtual Targeted Protein Degradation Day hosted by UBS.
Hace 5 días · See the latest Bristol-Myers Squibb Co stock price (BMY:XNYS), related news, valuation, dividends and more to help you make your investing decisions.
Hace 5 días · Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases.
Hace 2 días · Stock analysis for Bristol-Myers Squibb Co (BMY:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Hace 6 días · Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases.
Hace 5 días · Bristol-Myers Squibb has upgraded a long-running alliance with Prothena in Alzheimer’s disease, taking an option on a tau protein-targeting antibody in early-stage clinical development.
